焦炳华, 穆军, 许强芝, 缪辉南.海洋微生物来源新抗生素的研究[J].抗感染药学, 2004, 1（1）：1-9. [2] Carte BK. Biomedical potential of marine natral producta [J]. Bioscience, 1996, 46（4）：271-286. [3] J?rgensen BB, Boetius A. Feast and famine-microbial life in the deep-sea bed [J]. Nature Reviews Microbiology, 2001, 5：770-781. [4] Bernan VS, Greenstein M, Carter GT. Mining marine microorganisms as a source of new antimicrobials and antifungals [J]. Curr Med Chem-Anti-Infective Agents, 2004, 3（3）：181-195. [5] 林永成, 周世宁.海洋微生物及其代谢产物[M].北京：化学工业出版社, 2003. [6] Imada C. Enzyme inhibitors and other bioactive compounds from marine actinomycetes [J]. Antonie van Leeuwenhoek, 2005, 87（1）：59-63. [7] Cho JY, Williams PG, Kwon HC, et al. Lucentamycins A-D, cytotoxic peptides from the marine-derived actinomycete Nocardiopsis lucente-nsis [J]. Journal of Natural Products, 2007, 70（8）：1321-1328. [8] Lam KS. Discovery of novel metabolites from marine actinomycetes [J]. Current Opinion in Microbiology, 2006, 9：245-251. [9] 李富超.胶州湾两株海洋放线菌次级代谢产物的研究[D].北京：中国科学院研究生院, 2004. [10] Lu YJ, Dong X, Liu S, Bie X. Characterization and identification of a novel marine Streptomyces sp. produced antibacterial substance [J]. Marine Biotechnology, 2009, 11（6）：717-724. [11] Belofsky GN, Anguera M, Jensen PR, et al. Oxepinamides A-C and fumiquinazolines H-I：bioactive metabolites from a marine isolate of a fungus of the genus Acremonium [J]. Chemistry-A European Journal, 2000, 6（8）：1355-1360. [12] Buchanan RE, Gibbons NE. 伯杰细菌鉴定手册[M].北京：科学出版社, 1984：729-795. [13] 中国科学院微生物所放线菌分类组.链霉菌鉴定手册[M].北京：科学出版社, 1975：658-665. [14] Weisburg WG, Barns SM, Pelletier DA. 16S ribosomal DNA amplification for phylogenetic study [J]. Journal of Bacteriology, 1991, 173（2）：697-703. [15] Kumar S, Tamura K, Nei M. MEGA3：Integrated software or molecular evolutionary genetics analysis and sequence alignment [J]. Briefings in Bioinformatics, 2004, 5（2）：150-163. [16] Monaghan RL, Barrett JF. Antibacterial drug discovery-then, now and the genomics future [J]. Biochemical Pharmacology, 2006, 71（7）：901-909. [17] Nallapareddy SR, Duh RW, Singh KV, Murray BE. Molecular typing of selected Enterococcus faecalis isolates：pilot study using multilocussequence typing and pulsed-field gel electrophoresis [J]. Journal of Clinical Microbiology, 2002, 40（3）：868-876. [18] Moellering RC Jr. NDM-1-a cause for worldwide concern [J]. N Enql J Med, 2010, 363（25）：2377-2379. [19] Jensen PR, Mincer TJ, Williams PG, Fenical W. Marine actinomyc-ete diversity and natrual product discovery[J]. Antonie van Lee-uwenhoek, 2004, 87：43-48. [20] 田新朋, 张偲, 李文均.海洋放线菌研究进展[J].微生物学报, 2011, 51（2）：161-169. [21] Sivakumar K, Sahu MK, Thangaradjou T, Kannan L. Research on marine actinobacteria in India [J]. Indian Journal of Microbiology, 2007, 47：186-196. [22] 孙建龙, 于基成, 刘志恒, 等.一株拮抗番茄溃疡病菌的海洋放线菌的分类鉴定及活性测定[J].吉林农业大学学报, 2012, 34（4）：391-394. [23] 康银花, 王旻.抗MRSA小链霉菌NIM 521发酵工艺的优化[J].药物生物技术, 2008, 15（3）：208-211. [24] 田兆丰, 刘伟成, 刘霆, 董丹.小链霉菌Yn168发酵产物抗植物病毒活性的研究[J].中国生物防治学报, 2011, 27（4）：569-572.
